Cargando…
Novel therapeutic approach to slow down the inflammatory cascade in acute/subacute spinal cord injury: Early immune therapy with lipopolysaccharide enhanced neuroprotective effect of combinational therapy of granulocyte colony-stimulating factor and bone-marrow mesenchymal stem cell in spinal cord injury
Bone-marrow mesenchymal stem cells (BM-MSCs) have not yet proven any significant therapeutic efficacy in spinal cord injury (SCI) clinical trials, due to the hostile microenvironment of the injured spinal cord at the acute phase. This study aims to modulate the inflammatory milieu by lipopolysacchar...
Autores principales: | Hashemizadeh, Shiva, Hosseindoost, Saereh, Omidi, Ameneh, Aminianfar, Hossein, Ebrahimi-Barough, Somayeh, Ai, Jafar, Arjmand, Babak, Hadjighassem, Mahmoudreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727083/ https://www.ncbi.nlm.nih.gov/pubmed/36505513 http://dx.doi.org/10.3389/fncel.2022.993019 |
Ejemplares similares
-
Long-term administration of bumetanide improve functional recovery after spinal cord injury in rats
por: Hashemizadeh, Shiva, et al.
Publicado: (2022) -
Advances in Management of Spinal Cord Injury Using Stem Cell-derived Extracellular Vesicles: A Review Study
por: Afsartala, Zohreh, et al.
Publicado: (2023) -
β2-Adrenergic receptor agonist enhances the bystander effect of HSV-TK/GCV gene therapy in glioblastoma multiforme via upregulation of connexin 43 expression
por: Hosseindoost, Saereh, et al.
Publicado: (2022) -
Analgesic Effect of Bumetanide on Neuropathic Pain in Patients With Spinal Cord Injury
por: Nasirinezhad, Farinaz, et al.
Publicado: (2021) -
Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury
por: Derakhshanrad, Nazi, et al.
Publicado: (2015)